Keywords: hafslund, nycomed, first, half, sales, up, norwegian

HAFSLUND NYCOMED FIRST HALF SALES UP

Article | 09 August 1993

Norwegian pharmaceuticals and energy concern Hafslund Nycomed has reported sales for the first half of 1993 at 3.15 billion Norwegian kroner ($428.9 million). ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Nycomed

Go to company listing

Related Drugs

Gadodiamide

Omniscan

Go to drug listing